Cargando…
Lysozyme nephropathy in chronic myelomonocytic leukemia
Lysozyme nephropathy is a frequently unrecognized cause of renal disease in chronic myelomonocytic leukemia and may serve as a novel indication for treatment in this patient population. We demonstrate that in newly diagnosed CMML patients, plasma lysozyme levels are positively correlated with both a...
Autores principales: | Patel, Ami B., Miles, Rodney R., Deininger, Michael W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6553339/ https://www.ncbi.nlm.nih.gov/pubmed/31183108 http://dx.doi.org/10.1002/ccr3.2188 |
Ejemplares similares
-
Giant Cell Arteritis with Concomitant Chronic Myelomonocytic Leukemia
por: Öztaş, Mert, et al.
Publicado: (2021) -
Phenotypic Characterization of Leukemia-Initiating Stem Cells in Chronic Myelomonocytic Leukemia
por: Eisenwort, Gregor, et al.
Publicado: (2021) -
Clinicopathologic Spectrum of Lysozyme-Associated Nephropathy
por: Kudose, Satoru, et al.
Publicado: (2023) -
A case of acute myelomonocytic leukemia morphologically mimicking lymphoblastic leukemia
por: Ni, Sao‐Chih, et al.
Publicado: (2023) -
RAPID CONVERSION OF CHRONIC MYELOID LEUKEMIA TO CHRONIC MYELOMONOCYTIC LEUKEMIA IN A PATIENT ON IMATINIB THERAPY
por: Khorashad, Jamshid S., et al.
Publicado: (2016)